000 | 01520 a2200433 4500 | ||
---|---|---|---|
005 | 20250512033303.0 | ||
264 | 0 | _c19890420 | |
008 | 198904s 0 0 eng d | ||
022 | _a0315-162X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBellamy, N | |
245 | 0 | 0 |
_aValidation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. _h[electronic resource] |
260 |
_bThe Journal of rheumatology _cDec 1988 |
||
300 |
_a1833-40 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aConsumer Behavior |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aEvaluation Studies as Topic |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHealth Status Indicators |
650 | 0 | 4 | _aHealth Surveys |
650 | 0 | 4 |
_aHip Joint _xphysiopathology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKnee Joint _xphysiopathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOsteoarthritis _xdrug therapy |
650 | 0 | 4 |
_aPain _xdrug therapy |
650 | 0 | 4 |
_aPiroxicam _xanalogs & derivatives |
650 | 0 | 4 | _aRandom Allocation |
700 | 1 | _aBuchanan, W W | |
700 | 1 | _aGoldsmith, C H | |
700 | 1 | _aCampbell, J | |
700 | 1 | _aStitt, L W | |
773 | 0 |
_tThe Journal of rheumatology _gvol. 15 _gno. 12 _gp. 1833-40 |
|
999 |
_c3074175 _d3074175 |